Cargando…

Characterization of three new serous epithelial ovarian cancer cell lines

BACKGROUND: Cell lines constitute a powerful model to study cancer, and here we describe three new epithelial ovarian cancer (EOC) cell lines derived from poorly differentiated serous solid tumors (TOV-1946, and TOV-2223G), as well as the matched ascites for one case (OV-1946). METHODS: In addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouellet, Véronique, Zietarska, Magdalena, Portelance, Lise, Lafontaine, Julie, Madore, Jason, Puiffe, Marie-Line, Arcand, Suzanna L, Shen, Zhen, Hébert, Josée, Tonin, Patricia N, Provencher, Diane M, Mes-Masson, Anne-Marie
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2467432/
https://www.ncbi.nlm.nih.gov/pubmed/18507860
http://dx.doi.org/10.1186/1471-2407-8-152
_version_ 1782157456575561728
author Ouellet, Véronique
Zietarska, Magdalena
Portelance, Lise
Lafontaine, Julie
Madore, Jason
Puiffe, Marie-Line
Arcand, Suzanna L
Shen, Zhen
Hébert, Josée
Tonin, Patricia N
Provencher, Diane M
Mes-Masson, Anne-Marie
author_facet Ouellet, Véronique
Zietarska, Magdalena
Portelance, Lise
Lafontaine, Julie
Madore, Jason
Puiffe, Marie-Line
Arcand, Suzanna L
Shen, Zhen
Hébert, Josée
Tonin, Patricia N
Provencher, Diane M
Mes-Masson, Anne-Marie
author_sort Ouellet, Véronique
collection PubMed
description BACKGROUND: Cell lines constitute a powerful model to study cancer, and here we describe three new epithelial ovarian cancer (EOC) cell lines derived from poorly differentiated serous solid tumors (TOV-1946, and TOV-2223G), as well as the matched ascites for one case (OV-1946). METHODS: In addition to growth parameters, the cell lines were characterized for anchorage independent growth, migration and invasion potential, ability to form spheroids and xenografts in SCID mice. RESULTS: While all cell lines were capable of anchorage independent growth, only the TOV-1946 and OV-1946 cell lines were able to form spheroid and produce tumors. Profiling of keratins, p53 and Her2 protein expression was assessed by immunohistochemistry and western blot analyses. Somatic TP53 mutations were found in all cell lines, with TOV-1946 and OV-1946 harboring the same mutation, and none harbored the commonly observed somatic mutations in BRAF, KRAS or germline BRCA1/2 mutations found to recur in the French Canadian population. Conventional cytogenetics and spectral karyotype (SKY) analyses revealed complex karyotypes often observed in ovarian disease. CONCLUSION: This is the first report of the establishment of matched EOC cell lines derived from both solid tumor and ascites of the same patient.
format Text
id pubmed-2467432
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-24674322008-07-16 Characterization of three new serous epithelial ovarian cancer cell lines Ouellet, Véronique Zietarska, Magdalena Portelance, Lise Lafontaine, Julie Madore, Jason Puiffe, Marie-Line Arcand, Suzanna L Shen, Zhen Hébert, Josée Tonin, Patricia N Provencher, Diane M Mes-Masson, Anne-Marie BMC Cancer Research Article BACKGROUND: Cell lines constitute a powerful model to study cancer, and here we describe three new epithelial ovarian cancer (EOC) cell lines derived from poorly differentiated serous solid tumors (TOV-1946, and TOV-2223G), as well as the matched ascites for one case (OV-1946). METHODS: In addition to growth parameters, the cell lines were characterized for anchorage independent growth, migration and invasion potential, ability to form spheroids and xenografts in SCID mice. RESULTS: While all cell lines were capable of anchorage independent growth, only the TOV-1946 and OV-1946 cell lines were able to form spheroid and produce tumors. Profiling of keratins, p53 and Her2 protein expression was assessed by immunohistochemistry and western blot analyses. Somatic TP53 mutations were found in all cell lines, with TOV-1946 and OV-1946 harboring the same mutation, and none harbored the commonly observed somatic mutations in BRAF, KRAS or germline BRCA1/2 mutations found to recur in the French Canadian population. Conventional cytogenetics and spectral karyotype (SKY) analyses revealed complex karyotypes often observed in ovarian disease. CONCLUSION: This is the first report of the establishment of matched EOC cell lines derived from both solid tumor and ascites of the same patient. BioMed Central 2008-05-28 /pmc/articles/PMC2467432/ /pubmed/18507860 http://dx.doi.org/10.1186/1471-2407-8-152 Text en Copyright © 2008 Ouellet et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ouellet, Véronique
Zietarska, Magdalena
Portelance, Lise
Lafontaine, Julie
Madore, Jason
Puiffe, Marie-Line
Arcand, Suzanna L
Shen, Zhen
Hébert, Josée
Tonin, Patricia N
Provencher, Diane M
Mes-Masson, Anne-Marie
Characterization of three new serous epithelial ovarian cancer cell lines
title Characterization of three new serous epithelial ovarian cancer cell lines
title_full Characterization of three new serous epithelial ovarian cancer cell lines
title_fullStr Characterization of three new serous epithelial ovarian cancer cell lines
title_full_unstemmed Characterization of three new serous epithelial ovarian cancer cell lines
title_short Characterization of three new serous epithelial ovarian cancer cell lines
title_sort characterization of three new serous epithelial ovarian cancer cell lines
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2467432/
https://www.ncbi.nlm.nih.gov/pubmed/18507860
http://dx.doi.org/10.1186/1471-2407-8-152
work_keys_str_mv AT ouelletveronique characterizationofthreenewserousepithelialovariancancercelllines
AT zietarskamagdalena characterizationofthreenewserousepithelialovariancancercelllines
AT portelancelise characterizationofthreenewserousepithelialovariancancercelllines
AT lafontainejulie characterizationofthreenewserousepithelialovariancancercelllines
AT madorejason characterizationofthreenewserousepithelialovariancancercelllines
AT puiffemarieline characterizationofthreenewserousepithelialovariancancercelllines
AT arcandsuzannal characterizationofthreenewserousepithelialovariancancercelllines
AT shenzhen characterizationofthreenewserousepithelialovariancancercelllines
AT hebertjosee characterizationofthreenewserousepithelialovariancancercelllines
AT toninpatrician characterizationofthreenewserousepithelialovariancancercelllines
AT provencherdianem characterizationofthreenewserousepithelialovariancancercelllines
AT mesmassonannemarie characterizationofthreenewserousepithelialovariancancercelllines